Infectious Disease Society of America

1
Infectious Disease Society of America

• Andrew T. Pavia M.D.
• University of Utah

2
Background

• IDSA identified several key public policy
  priorities for action
• Based on importance, potential role of IDSA in
  bringing stakeholders together and influencing
  policy
• Antimicrobial Availability Task Force
• Pandemic Influenza Task Force

3
www.idsociety.org/ badbugsnodrugs
4
Bad Bugs, No Drugs

• Targets
• Scientific and medical community
• Industry
• Public
• Policymakers
• Premise Crisis is here, responses must be
  initiated now.
• Lays out menu of specific remedies

5
Recommendations in Bad Bugs, No Drugs

• Recommendations for Congress
• Recommendations for FDA
• Recommendations for NIAID
• New funding needed

6
IDSA LeadershipWalter Stamm, PresidentKathryn
Edwards, TreasurerPandemic Influenza Task Force

• David Fedson
• Haute Savoie, France
• Edward Janoff
• Univ of Minnesota
• Fred Hayden
• Univ of Virginia

• Kathleen Neuzil
• Univ of Washington
• Andrew Pavia (chair)
• Univ of Utah
• Gregory Poland
• Mayo Clinic

7
Actions to date

• Consultation with CDC, NIH
• Comments on the draft Pandemic Influenza Plan
• Education of the Public
• Media outreach
• Education of the Membership
• Symposium at 2005 annual meeting
• H2N2 mass email

8
Actions ContinuedFormulation of Priorities

• 1. Develop vaccine and antiviral supplies and
  establish a nation-wide tracking system
• 2. Strengthen liability protections during a
  declared emergency
• 3. Vaccination programs for health care workers

9
Actions ContinuedFormulation of Priorities

• 4. Improve education efforts
• 5. Financial Incentive to spur vaccine and
  antiviral R D
• 6. Strengthen agency responses
• 7. Improve coordination and planning

10
1. Develop vaccine and antiviral supplies and
establish a nation-wide tracking system

• Establish dedicated supplies of vaccine and
  antivirals for rapid response.
• Authorize and appropriate sufficient funds to
  establish an antiviral stockpile with sufficient
  drugs to treat 50 of the US population.
• Develop a coordinated plan for allocation and
  distribution of vaccine and antivirals.
• Ensure proper distribution, and if necessary,
  redistribuition with real-time tracking.
• Maintain and strengthen surveillance of vaccine
  efficacy, distribution, uptake and impact.

11
Actions ContinuedLegislative outreach

• Worked on specific proposals for bills
• Lieberman, Hatch, Cubin, Frist
• Met with members regarding upcoming legislation
• Frist
• Hatch
• Clinton
• Matheson